These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The parathyroid is a target organ for FGF23 in rats. Ben-Dov IZ; Galitzer H; Lavi-Moshayoff V; Goetz R; Kuro-o M; Mohammadi M; Sirkis R; Naveh-Many T; Silver J J Clin Invest; 2007 Dec; 117(12):4003-8. PubMed ID: 17992255 [TBL] [Abstract][Full Text] [Related]
43. Endocrine functions of bone in mineral metabolism regulation. Quarles LD J Clin Invest; 2008 Dec; 118(12):3820-8. PubMed ID: 19033649 [TBL] [Abstract][Full Text] [Related]
44. FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner. Murali SK; Roschger P; Zeitz U; Klaushofer K; Andrukhova O; Erben RG J Bone Miner Res; 2016 Jan; 31(1):129-42. PubMed ID: 26235988 [TBL] [Abstract][Full Text] [Related]
45. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23]. Shimizu Y; Fukumoto S Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274 [TBL] [Abstract][Full Text] [Related]
46. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277 [TBL] [Abstract][Full Text] [Related]
47. Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation. Yamashita H; Yamazaki Y; Hasegawa H; Yamashita T; Fukumoto S; Shigematsu T; Kazama JJ; Fukagawa M; Noguchi S Endocr J; 2007 Jun; 54(3):465-70. PubMed ID: 17464094 [TBL] [Abstract][Full Text] [Related]
48. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676 [TBL] [Abstract][Full Text] [Related]
49. FGF23 and Bone and Mineral Metabolism. Fukumoto S Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685 [TBL] [Abstract][Full Text] [Related]
50. The role of fibroblast growth factor-23 in cardiorenal syndrome. Kovesdy CP; Quarles LD Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553 [TBL] [Abstract][Full Text] [Related]
51. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409 [TBL] [Abstract][Full Text] [Related]
52. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism]. Fukumoto S Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990 [TBL] [Abstract][Full Text] [Related]